Regulatory Affair
The Regulatory Affairs Division of Egret Pharma is housed in its Beijing office. The Division is charged with all aspects of regulatory compliance and communication for clinical programs conducted in China. Individuals in this office are also responsible for tracking and insuring compliance with all legislative decisions and administrative rulings affecting the domestic jurisdictions in which Egret plans to distribute its products. The Regulatory Affairs Division is also responsible for all public communication of Egret information such as press releases, announcements and external communications.